The report highlights the company's progress in evolving its corporate governance, focusing on making a positive impact on patients, communities, and employees, and protecting the planet by reducing its environmental footprint. The report details the company's progress in achieving its five-year plan by doubling its commercial portfolio and R&D productivity. The report also showcases the company's commitment to human capital management, environmental stewardship, and stakeholder engagement.
Issuing Company Blueprint Medicines Corporation
Report Type Sustainability Report
Report Language EN
Report Filesize 3.85 MB
No. of Pages 44 pages
Reporting periodJanuary 1, 2022-December 31, 2022
Report Edition2
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue